- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Targeted RNA Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Targeted RNA Sequencing market size is estimated to be worth US$ 1852.7 million in 2021 and is forecast to a readjusted size of USD 7255.4 million by 2028 with a CAGR of 21.5% during review period. Research Institutes accounting for % of the Targeted RNA Sequencing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Exome Sequencing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Targeted RNA Sequencing include Thermo Fisher, Illumina, Roche Holdings, BGI, and Eurofins, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Targeted RNA Sequencing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Market segment by Application, can be divided into
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Market segment by players, this report covers
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Targeted RNA Sequencing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Targeted RNA Sequencing, with revenue, gross margin and global market share of Targeted RNA Sequencing from 2019 to 2022.
Chapter 3, the Targeted RNA Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Targeted RNA Sequencing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Targeted RNA Sequencing research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Targeted RNA Sequencing
1.2 Classification of Targeted RNA Sequencing by Type
1.2.1 Overview: Global Targeted RNA Sequencing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Targeted RNA Sequencing Revenue Market Share by Type in 2021
1.2.3 Exome Sequencing
1.2.4 Enrichment Sequencing
1.2.5 Amplicon Sequencing
1.3 Global Targeted RNA Sequencing Market by Application
1.3.1 Overview: Global Targeted RNA Sequencing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Global Targeted RNA Sequencing Market Size & Forecast
1.5 Global Targeted RNA Sequencing Market Size and Forecast by Region
1.5.1 Global Targeted RNA Sequencing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Targeted RNA Sequencing Market Size by Region, (2017-2022)
1.5.3 North America Targeted RNA Sequencing Market Size and Prospect (2017-2028)
1.5.4 Europe Targeted RNA Sequencing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Targeted RNA Sequencing Market Size and Prospect (2017-2028)
1.5.6 South America Targeted RNA Sequencing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Targeted RNA Sequencing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Targeted RNA Sequencing Market Drivers
1.6.2 Targeted RNA Sequencing Market Restraints
1.6.3 Targeted RNA Sequencing Trends Analysis
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Targeted RNA Sequencing Product and Solutions
2.1.4 Thermo Fisher Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina Targeted RNA Sequencing Product and Solutions
2.2.4 Illumina Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Illumina Recent Developments and Future Plans
2.3 Roche Holdings
2.3.1 Roche Holdings Details
2.3.2 Roche Holdings Major Business
2.3.3 Roche Holdings Targeted RNA Sequencing Product and Solutions
2.3.4 Roche Holdings Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Roche Holdings Recent Developments and Future Plans
2.4 BGI
2.4.1 BGI Details
2.4.2 BGI Major Business
2.4.3 BGI Targeted RNA Sequencing Product and Solutions
2.4.4 BGI Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 BGI Recent Developments and Future Plans
2.5 Eurofins
2.5.1 Eurofins Details
2.5.2 Eurofins Major Business
2.5.3 Eurofins Targeted RNA Sequencing Product and Solutions
2.5.4 Eurofins Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Eurofins Recent Developments and Future Plans
2.6 LabCorp
2.6.1 LabCorp Details
2.6.2 LabCorp Major Business
2.6.3 LabCorp Targeted RNA Sequencing Product and Solutions
2.6.4 LabCorp Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 LabCorp Recent Developments and Future Plans
2.7 Berry Genomics
2.7.1 Berry Genomics Details
2.7.2 Berry Genomics Major Business
2.7.3 Berry Genomics Targeted RNA Sequencing Product and Solutions
2.7.4 Berry Genomics Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Berry Genomics Recent Developments and Future Plans
2.8 Macrogen
2.8.1 Macrogen Details
2.8.2 Macrogen Major Business
2.8.3 Macrogen Targeted RNA Sequencing Product and Solutions
2.8.4 Macrogen Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Macrogen Recent Developments and Future Plans
2.9 GENEWIZ
2.9.1 GENEWIZ Details
2.9.2 GENEWIZ Major Business
2.9.3 GENEWIZ Targeted RNA Sequencing Product and Solutions
2.9.4 GENEWIZ Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 GENEWIZ Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Targeted RNA Sequencing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Targeted RNA Sequencing Players Market Share in 2021
3.2.2 Top 10 Targeted RNA Sequencing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Targeted RNA Sequencing Players Head Office, Products and Services Provided
3.4 Targeted RNA Sequencing Mergers & Acquisitions
3.5 Targeted RNA Sequencing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Targeted RNA Sequencing Revenue and Market Share by Type (2017-2022)
4.2 Global Targeted RNA Sequencing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Targeted RNA Sequencing Revenue Market Share by Application (2017-2022)
5.2 Global Targeted RNA Sequencing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Targeted RNA Sequencing Revenue by Type (2017-2028)
6.2 North America Targeted RNA Sequencing Revenue by Application (2017-2028)
6.3 North America Targeted RNA Sequencing Market Size by Country
6.3.1 North America Targeted RNA Sequencing Revenue by Country (2017-2028)
6.3.2 United States Targeted RNA Sequencing Market Size and Forecast (2017-2028)
6.3.3 Canada Targeted RNA Sequencing Market Size and Forecast (2017-2028)
6.3.4 Mexico Targeted RNA Sequencing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Targeted RNA Sequencing Revenue by Type (2017-2028)
7.2 Europe Targeted RNA Sequencing Revenue by Application (2017-2028)
7.3 Europe Targeted RNA Sequencing Market Size by Country
7.3.1 Europe Targeted RNA Sequencing Revenue by Country (2017-2028)
7.3.2 Germany Targeted RNA Sequencing Market Size and Forecast (2017-2028)
7.3.3 France Targeted RNA Sequencing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Targeted RNA Sequencing Market Size and Forecast (2017-2028)
7.3.5 Russia Targeted RNA Sequencing Market Size and Forecast (2017-2028)
7.3.6 Italy Targeted RNA Sequencing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Targeted RNA Sequencing Revenue by Type (2017-2028)
8.2 Asia-Pacific Targeted RNA Sequencing Revenue by Application (2017-2028)
8.3 Asia-Pacific Targeted RNA Sequencing Market Size by Region
8.3.1 Asia-Pacific Targeted RNA Sequencing Revenue by Region (2017-2028)
8.3.2 China Targeted RNA Sequencing Market Size and Forecast (2017-2028)
8.3.3 Japan Targeted RNA Sequencing Market Size and Forecast (2017-2028)
8.3.4 South Korea Targeted RNA Sequencing Market Size and Forecast (2017-2028)
8.3.5 India Targeted RNA Sequencing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Targeted RNA Sequencing Market Size and Forecast (2017-2028)
8.3.7 Australia Targeted RNA Sequencing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Targeted RNA Sequencing Revenue by Type (2017-2028)
9.2 South America Targeted RNA Sequencing Revenue by Application (2017-2028)
9.3 South America Targeted RNA Sequencing Market Size by Country
9.3.1 South America Targeted RNA Sequencing Revenue by Country (2017-2028)
9.3.2 Brazil Targeted RNA Sequencing Market Size and Forecast (2017-2028)
9.3.3 Argentina Targeted RNA Sequencing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Targeted RNA Sequencing Revenue by Type (2017-2028)
10.2 Middle East & Africa Targeted RNA Sequencing Revenue by Application (2017-2028)
10.3 Middle East & Africa Targeted RNA Sequencing Market Size by Country
10.3.1 Middle East & Africa Targeted RNA Sequencing Revenue by Country (2017-2028)
10.3.2 Turkey Targeted RNA Sequencing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Targeted RNA Sequencing Market Size and Forecast (2017-2028)
10.3.4 UAE Targeted RNA Sequencing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Targeted RNA Sequencing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Targeted RNA Sequencing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Targeted RNA Sequencing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Targeted RNA Sequencing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Targeted RNA Sequencing Revenue Market Share by Region (2023-2028)
Table 6. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Major Business
Table 8. Thermo Fisher Targeted RNA Sequencing Product and Solutions
Table 9. Thermo Fisher Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Illumina Corporate Information, Head Office, and Major Competitors
Table 11. Illumina Major Business
Table 12. Illumina Targeted RNA Sequencing Product and Solutions
Table 13. Illumina Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Roche Holdings Corporate Information, Head Office, and Major Competitors
Table 15. Roche Holdings Major Business
Table 16. Roche Holdings Targeted RNA Sequencing Product and Solutions
Table 17. Roche Holdings Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. BGI Corporate Information, Head Office, and Major Competitors
Table 19. BGI Major Business
Table 20. BGI Targeted RNA Sequencing Product and Solutions
Table 21. BGI Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Eurofins Corporate Information, Head Office, and Major Competitors
Table 23. Eurofins Major Business
Table 24. Eurofins Targeted RNA Sequencing Product and Solutions
Table 25. Eurofins Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. LabCorp Corporate Information, Head Office, and Major Competitors
Table 27. LabCorp Major Business
Table 28. LabCorp Targeted RNA Sequencing Product and Solutions
Table 29. LabCorp Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Berry Genomics Corporate Information, Head Office, and Major Competitors
Table 31. Berry Genomics Major Business
Table 32. Berry Genomics Targeted RNA Sequencing Product and Solutions
Table 33. Berry Genomics Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Macrogen Corporate Information, Head Office, and Major Competitors
Table 35. Macrogen Major Business
Table 36. Macrogen Targeted RNA Sequencing Product and Solutions
Table 37. Macrogen Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. GENEWIZ Corporate Information, Head Office, and Major Competitors
Table 39. GENEWIZ Major Business
Table 40. GENEWIZ Targeted RNA Sequencing Product and Solutions
Table 41. GENEWIZ Targeted RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Targeted RNA Sequencing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Targeted RNA Sequencing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Targeted RNA Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Targeted RNA Sequencing Players Head Office, Products and Services Provided
Table 46. Targeted RNA Sequencing Mergers & Acquisitions in the Past Five Years
Table 47. Targeted RNA Sequencing New Entrants and Expansion Plans
Table 48. Global Targeted RNA Sequencing Revenue (USD Million) by Type (2017-2022)
Table 49. Global Targeted RNA Sequencing Revenue Share by Type (2017-2022)
Table 50. Global Targeted RNA Sequencing Revenue Forecast by Type (2023-2028)
Table 51. Global Targeted RNA Sequencing Revenue by Application (2017-2022)
Table 52. Global Targeted RNA Sequencing Revenue Forecast by Application (2023-2028)
Table 53. North America Targeted RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Targeted RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Targeted RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Targeted RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Targeted RNA Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Targeted RNA Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Targeted RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Targeted RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Targeted RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Targeted RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Targeted RNA Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Targeted RNA Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Targeted RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Targeted RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Targeted RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Targeted RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Targeted RNA Sequencing Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Targeted RNA Sequencing Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Targeted RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Targeted RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Targeted RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Targeted RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Targeted RNA Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Targeted RNA Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Targeted RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Targeted RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Targeted RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Targeted RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Targeted RNA Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Targeted RNA Sequencing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Targeted RNA Sequencing Picture
Figure 2. Global Targeted RNA Sequencing Revenue Market Share by Type in 2021
Figure 3. Exome Sequencing
Figure 4. Enrichment Sequencing
Figure 5. Amplicon Sequencing
Figure 6. Targeted RNA Sequencing Revenue Market Share by Application in 2021
Figure 7. Research Institutes Picture
Figure 8. Hospitals & Clinics Picture
Figure 9. Biotechnology Company Picture
Figure 10. Diagnostic Lab Picture
Figure 11. Global Targeted RNA Sequencing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Targeted RNA Sequencing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Targeted RNA Sequencing Revenue Market Share by Region (2017-2028)
Figure 14. Global Targeted RNA Sequencing Revenue Market Share by Region in 2021
Figure 15. North America Targeted RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Targeted RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Targeted RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Targeted RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Targeted RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Targeted RNA Sequencing Market Drivers
Figure 21. Targeted RNA Sequencing Market Restraints
Figure 22. Targeted RNA Sequencing Market Trends
Figure 23. Thermo Fisher Recent Developments and Future Plans
Figure 24. Illumina Recent Developments and Future Plans
Figure 25. Roche Holdings Recent Developments and Future Plans
Figure 26. BGI Recent Developments and Future Plans
Figure 27. Eurofins Recent Developments and Future Plans
Figure 28. LabCorp Recent Developments and Future Plans
Figure 29. Berry Genomics Recent Developments and Future Plans
Figure 30. Macrogen Recent Developments and Future Plans
Figure 31. GENEWIZ Recent Developments and Future Plans
Figure 32. Global Targeted RNA Sequencing Revenue Share by Players in 2021
Figure 33. Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Targeted RNA Sequencing Revenue Market Share in 2021
Figure 35. Global Top 10 Players Targeted RNA Sequencing Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Targeted RNA Sequencing Revenue Share by Type in 2021
Figure 38. Global Targeted RNA Sequencing Market Share Forecast by Type (2023-2028)
Figure 39. Global Targeted RNA Sequencing Revenue Share by Application in 2021
Figure 40. Global Targeted RNA Sequencing Market Share Forecast by Application (2023-2028)
Figure 41. North America Targeted RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 42. North America Targeted RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 43. North America Targeted RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 44. United States Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Targeted RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 48. Europe Targeted RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 49. Europe Targeted RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 50. Germany Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Targeted RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Targeted RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Targeted RNA Sequencing Revenue Market Share by Region (2017-2028)
Figure 58. China Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Targeted RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 65. South America Targeted RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 66. South America Targeted RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Targeted RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Targeted RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Targeted RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Targeted RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
